926276-15-5 Usage
Description
(1S,3aR,6aS)-tert-butyl 2-((S)-2-(benzyloxycarbonylamino)-3,3-dimethylbutanoyl)octahydrocyclopenta[c]pyrrole-1-carboxylate is a complex ester derivative featuring a tert-butyl group attached to the cyclopentane ring. It also incorporates an acyl group and an amino acid derivative, specifically benzyloxycarbonylamino, which is connected to the 2-position of the cyclopentane ring. This intricate structure endows it with potential bioactivity and utility in pharmaceuticals or chemical research, making it a candidate for further study and analysis to explore its properties and applications.
Uses
Used in Pharmaceutical Industry:
(1S,3aR,6aS)-tert-butyl 2-((S)-2-(benzyloxycarbonylamino)-3,3-dimethylbutanoyl)octahydrocyclopenta[c]pyrrole-1-carboxylate is used as a potential bioactive compound for the development of new drugs. Its unique structure may contribute to specific therapeutic effects, warranting further research into its pharmacological properties and potential medical applications.
Used in Chemical Research:
In the field of chemical research, (1S,3aR,6aS)-tert-butyl 2-((S)-2-(benzyloxycarbonylamino)-3,3-dimethylbutanoyl)octahydrocyclopenta[c]pyrrole-1-carboxylate serves as a valuable building block for the synthesis of other complex organic compounds. Its versatile structure allows for various chemical modifications, facilitating the exploration of new chemical pathways and the creation of novel molecules with potential applications in different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 926276-15-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,6,2,7 and 6 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 926276-15:
(8*9)+(7*2)+(6*6)+(5*2)+(4*7)+(3*6)+(2*1)+(1*5)=185
185 % 10 = 5
So 926276-15-5 is a valid CAS Registry Number.
926276-15-5Relevant articles and documents
PROCESSES AND INTERMEDIATES
-
, (2012/12/13)
A process for preparing enantioselectively a compound of formula la or lb: over a compound of formulas 1-2 - Ih:
Processes and intermediates
-
Page/Page column 44; 45, (2010/11/26)
The invention relates to compounds and processes useful for the preparation of protease inhibitors, particularly serine protease inhibitors. The protease inhibitors are useful for treatment of HCV infections.
